Literature DB >> 26003442

Targeting CD151 by lentivirus-mediated RNA interference inhibits luminal and basal-like breast cancer cell growth and invasion.

Ting Liu1, Shaoqing wang, Liping Wang, Junping Wang, Yulin Li.   

Abstract

CD151 is a member of the tetraspanin family, which is involved in diverse cellular processes, including proliferation, motility, and invasion. However, the role of CD151 in breast cancer especially luminal and basal-like subtype breast cancer remains obscure. Here, we report the role of CD151 in the biological behaviors of luminal and basal-like subtype cell lines and the underlying molecular mechanism. A eukaryotic expression vector expressing both CD151 shRNA and GFP was transfected into MCF-7 and MDA-MB-468 cells. The CD151 gene-silencing effect is authenticated by real-time PCR and Western blot. Our data show that the capacity for proliferation, migration, and invasion of two kinds of cells is diminished after Knockdown of CD151 via lentivirus-mediated CD151 specific shRNA. Tumor cells are arrested in G0/G1 phase. Apoptosis is increased. Moreover, we also demonstrate that the expressions of mmp26 and CD147 are inhibited by knockdown of CD151. But the inhibition depends on the cell type. We can conclude that silencing gene CD151 inhibits expression of properties that are associated with the malignant phenotype of MCF-7 and MDA-MB-468 cells. It may become a potential target in breast cancer therapy especially for luminal and basal subtypes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26003442     DOI: 10.1007/s11010-015-2459-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways.

Authors:  In-Kee Hong; Young-June Jin; Hee-Jung Byun; Doo-Il Jeoung; Young-Myeong Kim; Hansoo Lee
Journal:  J Biol Chem       Date:  2006-06-23       Impact factor: 5.157

2.  CD151 dynamics in carcinoma-stroma interaction: integrin expression, adhesion strength and proteolytic activity.

Authors:  Masakazu Hasegawa; Mitsuko Furuya; Yoshitoshi Kasuya; Mariko Nishiyama; Tsuyoshi Sugiura; Takashi Nikaido; Yutaka Momota; Masaharu Ichinose; Sadao Kimura
Journal:  Lab Invest       Date:  2007-07-16       Impact factor: 5.662

3.  Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis.

Authors:  Xin A Zhang; Alexander R Kazarov; Xiuwei Yang; Alexa L Bontrager; Christopher S Stipp; Martin E Hemler
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

4.  Clinical significance of CD151 gene expression in non-small cell lung cancer.

Authors:  T Tokuhara; H Hasegawa; N Hattori; H Ishida; T Taki; S Tachibana; S Sasaki; M Miyake
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

5.  Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor.

Authors:  H I Park; J Ni; F E Gerkema; D Liu; V E Belozerov; Q X Sang
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

Review 6.  Lentiviral delivery of short hairpin RNAs.

Authors:  N Manjunath; Haoquan Wu; Sandesh Subramanya; Premlata Shankar
Journal:  Adv Drug Deliv Rev       Date:  2009-03-31       Impact factor: 15.470

7.  Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer.

Authors:  Toshiki Funakoshi; Isao Tachibana; Yoshihiko Hoshida; Hiromi Kimura; Yoshito Takeda; Takashi Kijima; Kazumi Nishino; Hiroyuki Goto; Tsutomu Yoneda; Toru Kumagai; Tadashi Osaki; Seiji Hayashi; Katsuyuki Aozasa; Ichiro Kawase
Journal:  Oncogene       Date:  2003-02-06       Impact factor: 9.867

8.  Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China.

Authors:  Cong Xue; Xi Wang; Roujun Peng; Yanxia Shi; Tao Qin; Donggen Liu; Xiaoyu Teng; Shusen Wang; Li Zhang; Zhongyu Yuan
Journal:  Cancer Sci       Date:  2012-07-04       Impact factor: 6.716

9.  Clinical significance of transmembrane 4 superfamily in colon cancer.

Authors:  H Hashida; A Takabayashi; T Tokuhara; N Hattori; T Taki; H Hasegawa; S Satoh; N Kobayashi; Y Yamaoka; M Miyake
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

10.  Clinicopathologic features of triple negative breast cancers: an experience from Pakistan.

Authors:  Atif Ali Hashmi; Muhammad Muzzammil Edhi; Hanna Naqvi; Naveen Faridi; Amna Khurshid; Mehmood Khan
Journal:  Diagn Pathol       Date:  2014-02-28       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.